The store will not work correctly when cookies are disabled.
8-Chloro-3-(5-imidazol-1-yl-pentyl)-1H-quinazoline-2,4-dione
ID: ALA73158
Chembl Id: CHEMBL73158
PubChem CID: 13952791
Max Phase: Preclinical
Molecular Formula: C16H17ClN4O2
Molecular Weight: 332.79
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1[nH]c2c(Cl)cccc2c(=O)n1CCCCCn1ccnc1
Standard InChI: InChI=1S/C16H17ClN4O2/c17-13-6-4-5-12-14(13)19-16(23)21(15(12)22)9-3-1-2-8-20-10-7-18-11-20/h4-7,10-11H,1-3,8-9H2,(H,19,23)
Standard InChI Key: FPHKLPYHUMXACE-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.79 | Molecular Weight (Monoisotopic): 332.1040 | AlogP: 2.41 | #Rotatable Bonds: 6 |
Polar Surface Area: 72.68 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.14 | CX Basic pKa: 6.54 | CX LogP: 3.15 | CX LogD: 3.11 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.70 | Np Likeness Score: -1.51 |
References
1. Wright WB, Tomcufcik AS, Chan PS, Marsico JW, Press JB.. (1987) Thromboxane synthetase inhibitors and antihypertensive agents. 4. N-[(1H-imidazol-1-yl)alkyl] derivatives of quinazoline-2,4(1H,3H)-diones, quinazolin-4(3H)-ones, and 1,2,3-benzotriazin-4(3H)-ones., 30 (12): [PMID:3681898] [10.1021/jm00395a016] |